Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9385710 | Respiratory Medicine | 2005 | 10 Pages |
Abstract
In this study, formoterol 9 μg bid via Turbuhaler® as maintenance therapy, with either formoterol or terbutaline as rescue medication, provided sustained improvements in lung function and COPD symptoms. Both formoterol regimens were well tolerated with no differences in adverse events or electrocardiogram profiles.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Malcolm Campbell, Abraham Eliraz, Gunnar Johansson, Göran Tornling, Ulf Nihlén, Thomas Bengtsson, Klaus F. Rabe,